Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Clinical and Translational Medicine|November 16, 2024
Persistence of activated anti-mesothelin hYP218 chimeric antigen receptor T cells in the tumour is associated with efficacy in gastric and colorectal carcinomasSameer Mir, Abhilash Venugopalan, Jingli Zhang, et al.Molecular Cancer Therapeutics|May 2, 2022
Development of Highly Effective Anti-Mesothelin hYP218 Chimeric Antigen Receptor T Cells With Increased Tumor Infiltration and Persistence for Treating Solid TumorsSakshi Tomar, Jingli Zhang, Manakamana Khanal, et al.Molecular Therapy. Methods & Clinical Development|June 14, 2019
Investigational RNAi Therapeutic Targeting C5 Is Efficacious in Pre-clinical Models of Myasthenia GravisLinda L Kusner, Kristina Yucius, Manjistha Sengupta, et al.Science Translational Medicine|July 3, 2020
Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor modelsQun Jiang, Azam Ghafoor, Idrees Mian, et al.JTO Clinical and Research Reports|October 18, 2021
Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> GeneAzam Ghafoor, Idrees Mian, Cathy Wagner, et al.Cell Reports. Medicine|February 11, 2023
Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesotheliomaNishanth Ulhas Nair, Qun Jiang, Jun Stephen Wei, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 1, 2020
Sensitivity of Mesothelioma Cells to PARP Inhibitors Is Not Dependent on BAP1 but Is Enhanced by Temozolomide in Cells With High-Schlafen 11 and Low-O6-methylguanine-DNA Methyltransferase ExpressionDaniel Rathkey, Manakamana Khanal, Junko Murai, et al.Pageof 2